Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-17 Sale | 2026-09-21 3:20 pm | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 52,500 | $37.89 | $1,989,409 | 15,167 (Direct) | View |
| 2026-05-20 Sale | 2026-05-22 2:54 pm | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 10,000 | $29.32 | $293,166 | 26,167 (Direct) | View |
| 2026-01-02 Purchase | 2026-01-06 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 10,000 | $3.44 | $34,400 | 50,000 (Direct) | View |
| 2025-08-27 Purchase | 2025-08-27 8:54 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 10,000 | $3.41 | $34,100 | 40,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-17 Exercise | 2026-09-21 3:20 pm | N/A N/A | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 17,500 | $18.14 | 15,167 (Direct) | View |
| 2026-09-17 Exercise | 2026-09-21 3:20 pm | N/A N/A | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 35,000 | $14.39 | 15,167 (Direct) | View |
| 2026-09-17 Exercise | 2026-09-21 3:20 pm | N/A 2032-01-01 | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 52,500 | $0 | 15,167 (Direct) | View |
| 2026-05-20 Exercise | 2026-05-22 2:54 pm | N/A 2033-04-06 | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 10,000 | $0 | 26,167 (Direct) | View |
| 2026-05-20 Exercise | 2026-05-22 2:54 pm | N/A N/A | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 10,000 | $8.05 | 26,167 (Direct) | View |
Ownership | 2026-03-18 2:23 pm | N/A N/A | Pharvaris N.V. | PHVS | Bjork Elisabeth Director | 0 | $0 | 134,167 (Direct) | View |
| 2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-09-26 Option Award | 2024-10-29 5:05 pm | N/A 2034-09-26 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 607 | $0 | 607 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-20 4:10 pm | N/A 2034-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 3,325 | $15.04 | 27,269 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-20 4:10 pm | N/A 2034-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 23,944 | $0 | 27,269 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:47 pm | N/A 2033-06-22 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 3,590 | $13.93 | 29,440 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 7:47 pm | N/A 2033-06-22 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 25,850 | $0 | 29,440 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 7,345 | $6.8 | 55,090 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 47,745 | $0 | 55,090 (Direct) | View |